News

After nearly four decades, Barton Haynes, MD, has decided to step down as director of the Duke Human Vaccine Institute (DHVI).

Wilton Williams, PhD, an associate professor in surgery and DHVI member, has been named a recipient of the Ruth and A. Morris Williams Faculty Research Prize.

Nicholas Heaton, PhD, professor of molecular genetics and microbiology, is looking at host-targeted treatments for viral infections.

Distinguished professorships are awarded to faculty who have demonstrated extraordinary scholarship in advancing science and improving human health. 

On March 9, members of the Duke Human Vaccine Institute (DHVI) gathered virtually for the annual DHVI Service & Core Values Awards Ceremony to celebrate 

A new Nature Medicine paper highlights how 40 years of HIV research reshaped far more than the fight against one virus. What began as an urgent global health response helped fuel breakthroughs that now power treatments for cancer, tuberculosis, hepatitis, and even COVID-19 — thanks to sustained U.S. investment and collaboration across universities, industry, and government.

DHVI member Georgia Tomaras, PhD, the A. Geller Distinguished Professor for Research in Immunology received a Research Mentoring Award, which recognizes excellence in mentoring across clinical, translational, population health, and basic sciences. She was honored for career mentoring in basic science.

Duke Human Vaccine Institute (DHVI) director Barton F.

Duke University School of Medicine has joined the Global Virus Network (GVN) as one of its newest Centers of Excellence. Collaborating entities include the Duke Research and Discovery @RTP, the Duke Global Health Institute and the Duke Human Vaccine Institute (DHVI).

Highly specific HIV antibodies could be induced by vaccination using a new strategy developed by researchers at the Duke Human Vaccine Institute